ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,082,000 | +134.7% | 12,096 | +84.9% | 0.01% | +125.0% |
| Q1 2021 | $887,000 | +25.6% | 6,542 | +18.5% | 0.00% | 0.0% |
| Q4 2020 | $706,000 | +134.6% | 5,519 | +74.5% | 0.00% | +100.0% |
| Q2 2020 | $301,000 | +106.2% | 3,162 | +94.8% | 0.00% | +100.0% |
| Q1 2020 | $146,000 | -99.2% | 1,623 | -99.6% | 0.00% | -98.9% |
| Q1 2019 | $19,404,000 | +43020.0% | 416,666 | +40392.3% | 0.09% | – |
| Q4 2018 | $45,000 | -92.1% | 1,029 | -93.4% | 0.00% | -100.0% |
| Q3 2016 | $568,000 | – | 15,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |